SURG (SURG) Stock Price & Analysis
SURG (SURG) closed at USD 0.13 on Thursday, October 15, 2026, up 6.27% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.12; the Oct 15, 2026 session ranged USD 0.12–0.13 on volume of 4,276,651 shares. Market capitalization is $6.72M, with a 52-week range of USD 0.12–3.14 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SURG.md
Key facts (SURG)
- Analysts: Buy (mean 2.00 on a 1–5 scale) (1 analysts), mean target USD 3.75 (range 3.75–3.75).
- Total return with dividends: 1Y -95.3% vs S&P 500 +18.1%; 5Y -97.8% vs S&P 500 +85.1%.
Analysts (SURG)
Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 3.75 (low 3.75, high 3.75).
Total return (dividends reinvested) (SURG)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -95.3% | -97.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -95.4% | -53.3% |
| Volatility (annualized) | 125.7% | 91.1% |
| Max drawdown | -95.9% (Oct 2025→Oct 2026) | -98.5% (Feb 2024→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 0.13 |
|---|---|
| Change | ▲ 6.27% (up) |
| Previous Close | USD 0.12 |
| Open | USD 0.12 |
| Day Range | USD 0.12 – 0.13 |
| 52-Week Range | USD 0.12 – 3.14 |
| Volume | 4,276,651 shares |
| Market Cap | $6.72M |
| Exchange | NCM |
Technical Analysis (SURG)
Nexqual's technical model rates SURG "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:11 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 35.98 (neutral) |
| vs SMA50 | Below (USD 0.18) |
| MACD | -0.01 (negative) |
Analyst Ratings (SURG)
Wall Street analysts rate SURG "Buy" based on 1 analysts, with a mean price target of USD 3.75 (range USD 3.75–3.75), per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 3.75 |
| High Target | USD 3.75 |
| Low Target | USD 3.75 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Leadership (SURG)
SURG is led by Kevin Brian Cox (age 50), CEO, President & Chairman, per Nexqual as of October 16, 2026 at 05:11 UTC.
| CEO, President & Chairman | Kevin Brian Cox (age 50) |
|---|---|
| President of Sales & Operations | Derron Winfrey |
| Interim Chief Financial Officer | Chelsea Pullano (age 34) |
| Executive Vice President of Technology | Mark Garner |
| Executive Vice President of Strategy & Compliance | Jeremy Gies (age 50) |
Major Backers & Investors (SURG)
Notable institutional backers of SURG include Gaddis Premier Wealth Advisors LLC, Millennium Management, Cable Car Capital, LP, according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Gaddis Premier Wealth Advisors LLC | 0.83% |
| Millennium Management | 0.4% |
| Cable Car Capital, LP | 0.34% |
| Fidelity | 0.26% |
| Citadel | 0.16% |
| Cetera Investment Advisers | 0.12% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.3% |
| Geode Capital | 0.32% |
| State Street | 0.12% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TNON | Tenon Medical, Inc. | USD 2.91 | ▲ 0.69% |
| STXS | Stereotaxis, Inc. | USD 1.05 | ▼ 0.94% |
| AUUD | Auddia Inc. | USD 1.01 | ▼ 1.94% |
| CHAI | Core AI Holdings, Inc. | USD 0.21 | ▲ 0.05% |
| BJDX | Bluejay Diagnostics, Inc. | USD 0.78 | ▼ 6.33% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt